Clinical Trial Tracker — New Trials by Sponsor & Condition
Pricing
Pay per usage
Clinical Trial Tracker — New Trials by Sponsor & Condition
Search newly posted clinical trials by sponsor, condition, phase, status, or country. A new trial start is a buying signal for CROs, lab suppliers, and patient recruitment services.
Pricing
Pay per usage
Rating
0.0
(0)
Developer
Timothy Kelvin
Maintained by CommunityActor stats
0
Bookmarked
2
Total users
1
Monthly active users
8 days ago
Last modified
Categories
Share
Clinical Trial Tracker — New Trial Starts by Sponsor & Condition
Search newly posted clinical trials by sponsor, condition, phase, status, or country. A new trial start is a buying signal for CROs, lab and reagent suppliers, and patient recruitment services — a termination is a signal too, for competitive and risk-monitoring purposes.
Built for CRO/vendor business development tracking which sponsors are starting trials in their therapeutic area, and biotech competitive intelligence teams monitoring specific sponsors or conditions.
Input
{"condition": "oncology","sponsor": "Pfizer","phase": "all","status": "new","country": "Germany","daysBack": 14,"maxResults": 25}
| Field | Type | Description |
|---|---|---|
condition | string | Medical condition to search for. Leave blank to skip. |
sponsor | string | Lead sponsor organization name. Leave blank for all sponsors. |
phase | string | all, EARLY_PHASE1, PHASE1, PHASE2, PHASE3, PHASE4, or NA. Default all. |
status | string | new (recruiting/not-yet-recruiting — the trial-start signal), all, completed, or terminated (terminated/withdrawn/suspended — the trial-failure signal). Default new. |
country | string | Limit to trials with at least one site in this country. |
daysBack | number | How many days back from today to search, by first-posted date. Default 14, max 90. |
maxResults | number | Max trials to return, most recently posted first. Default 25, max 100. |
Output
One record per trial:
{"nctId": "NCT07755436","studyUrl": "https://clinicaltrials.gov/study/NCT07755436","briefTitle": "Phase 1 Study to Assess Safety, Tolerability... in Advanced or Metastatic Ovarian or Endometrial Cancer.","overallStatus": "RECRUITING","phases": ["PHASE1"],"leadSponsor": "ArriVent BioPharma, Inc.","conditions": ["Ovarian Cancer", "Endometrial Cancer"],"countries": ["United States"],"siteCount": 2,"briefSummary": "This is a Phase 1 study to assess safety, tolerability...","studyFirstPostDate": "2026-08-10","startDate": "2026-07-23"}
countries and siteCount summarize the trial's location list — large
multi-national trials can have hundreds of individual sites, so raw
site-level data isn't included in the row.
How it works
Direct calls to the official ClinicalTrials.gov v2 API — the U.S. National Library of Medicine's public registry, no API key required. No proxy, no login, no scraping.
Pricing note
Billed per search, not per trial returned — one charge whether the search returns 1 trial or 100.
Related products
Looking for other early-signal or risk-monitoring actors?
- Insider Trading Alert — executive stock buy/sell signals
- Product Recall Alert — FDA drug/food/device recalls